Basilea Pharmaceutica AG banner

Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager
Basilea Pharmaceutica AG Logo
Basilea Pharmaceutica AG
SIX:BSLN
Watchlist
Price: 52.1 CHF 0.58% Market Closed
Market Cap: CHf631.5m

Intrinsic Value

The intrinsic value of one BSLN stock under the Base Case scenario is 44.89 CHF. Compared to the current market price of 52.1 CHF, Basilea Pharmaceutica AG is Overvalued by 14%.

BSLN Intrinsic Value
44.89 CHF
Overvaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Basilea Pharmaceutica AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about BSLN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BSLN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Basilea Pharmaceutica AG.

Explain Valuation
Alternatives to BSLN

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one BSLN stock?

The intrinsic value of one BSLN stock under the Base Case scenario is 44.89 CHF.

Is BSLN stock undervalued or overvalued?

Compared to the current market price of 52.1 CHF, Basilea Pharmaceutica AG is Overvalued by 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett